Glucose control and vascular complications in veterans with type 2 diabetes

Cited by (1,057)

Items 901–1,000 of 1,057

1. Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia
   Andreas Holstein, Michael Hahn, Olaf M. Patzer, Angela Seeringer, Peter Louis Kovacs, Julia Stingl · 2011 · European Journal of Clinical Pharmacology
2. Diabetic cardiovascular autonomic neuropathy: clinical implications
   Georgios Karayannis, Grigorios Giamouzis, Dennis V. Cokkinos, John S. Skoularigis, Filippos K. Triposkiadis · 2012 · Expert Review of Cardiovascular Therapy
3. Insulin management of type 2 diabetes mellitus.
   Allison M Petznick · 2011 · PubMed
4. Representation of people of South Asian origin in cardiovascular outcome trials of glucose‐lowering therapies in Type 2 diabetes
   Kamlesh Khunti, Srikanth Bellary, Muhammad Ali Karamat, K. Patel, V. Patel, Angus G. Jones, Jeremy Gray, Peter Robin Shepherd, Wasim Hanif · 2016 · Diabetic Medicine
5. Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance
   Rumyana B. Dimova, Tsvetalina I. Tankova, Velina Guergueltcheva, Ivailo Tournev, Nevena Y. Chakarova, Greta G. Grozeva, Lilia N. Dakovska · 2016 · Journal of Diabetes and its Complications
6. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: T he EXAMINE trial
   Simon R. Heller, Richard M. Bergenstal, William B. White, Stuart Kupfer, George L. Bakris, William C. Cushman, C R Mehta, Steven E. Nissen, Craig Wilson, Faiez M. Zannad et al. · 2017 · Diabetes Obesity and Metabolism
7. Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
   James Xu, Rohan Rajaratnam · 2017 · Cardiovascular Diabetology
8. d-Ribose contributes to the glycation of serum protein
   Yao Chen, Lexiang Yu, Yujing Wang, Wei Yan, Yong Xu, Tao He, Rongqiao He · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
9. Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes Trials
   Irene Caruso, Angelo Cignarelli, Francesco Giorgino · 2019 · Trends in Endocrinology and Metabolism
10. Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: a comprehensive economic evaluation using clinical trial and real-world evidence
    McEwan, Phil, Bennett, Hayley, Khunti, Kamlesh, Wilding, John, Edmonds, Christopher, Thuresson, Marcus, Wittbrodt, Eric, Fenici, Peter, Kosiborod, Mikhail · 2020 · Diabetes, Obesity and Metabolism
11. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes
    Satomi Wakasugi, Tomoya Mita, Naoto Katakami, Yosuke Okada, Hidenori Yoshii, Takeshi Osonoi, Nobuichi Kuribayashi, Yoshinobu Taneda, Yuichi Kojima, Masahiko Gosho et al. · 2021 · Cardiovascular Diabetology
12. Managing hypoglycaemia
    Ahmed Iqbal, Simon R. Heller · 2016 · Best Practice & Research Clinical Endocrinology & Metabolism
13. Trends in Emergency Department Visit Rates for Hypoglycemia and Hyperglycemic Crisis among Adults with Diabetes, United States, 2006-2011
    Jing Wang, Linda S. Geiss, Desmond E. Williams, Edward W. Gregg · 2015 · PLoS ONE
14. Euglycemic progression: Worsening of diabetic retinopathy in poorly controlled type 2 diabetes in minorities
    A. Shurter, Pauline M. Genter, D. Ouyang, Eli Ipp · 2013 · Diabetes Research and Clinical Practice
15. Clinical therapeutic strategies for early stage of diabetic kidney disease
    Munehiro Kitada · 2014 · World Journal of Diabetes
16. Macrovascular complication phenotypes in type 2 diabetic patients
    Giuseppe Francesco Sferrazza Papa, Claudia Degano, Maria Pierangela Iurato, Carmelo Licciardello, Raffaella Maiorana, Concetta Finocchiaro · 2013 · Cardiovascular Diabetology
17. Trends in Myocardial Infarction Secondary Prevention: The National Health and Nutrition Examination Surveys (NHANES), 1999–2012
    Nilay S. Shah, Mark D. Huffman, Hongyan Ning, Donald M. Lloyd‐Jones · 2015 · Journal of the American Heart Association
18. Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes
    Ya-Fei Yang, Tsai‐Chung Li, Chia‐Ing Li, Chiu-Shong Liu, Wen‐Yuan Lin, Sing-Yu Yang, Jen‐Huai Chiang, Chiu-Ching Huang, Fung‐Chang Sung, Cheng‐Chieh Lin · 2015 · Medicine
19. Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways
    Kar Sheng Lew, James T. Pearson, Daryl O. Schwenke, Rajesh Katare · 2017 · Cardiovascular Diabetology
20. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)
    Marcello Casaccia Bertoluci, Rodrigo O. Moreira, André Árpád Faludi, Maria Cristina de Oliveira Izar, Beatriz D'Agord Schaan, Cynthia Melissa Valério, Marcelo Chiara Bertolami, Ana Paula Marte Chacra, Marcus Vinícius Bolívar Malachias, Sérgio Alberto Cunha Vencio et al. · 2017 · Diabetology & Metabolic Syndrome
21. Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients
    Anca Moțățăianu, Smaranda Maier, Zoltán Bajkó, Septimiu Toader Voidăzan, Rodica Bălașa, Adina Stoian · 2018 · BMC Neurology
22. Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes.
    Greene, Stephen J., Vaduganathan, Muthiah, Khan, Muhammad Shahzeb, Bakris, George L., Weir, Matthew R., Seltzer, Jonathan H., Sattar, Naveed, McGuire, Darren K., Januzzi, James L., Stockbridge, Norman et al. · 2018 · Journal of the American College of Cardiology
23. Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
    Junyu Pei, Xiaopu Wang, Zeyu Pei, Xinqun Hu · 2023 · Cardiovascular Diabetology
24. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review
    İbrahim Şahin, Okan Bakıner, Tevfik Demir, Ramazan Sari, Ayşegül Akın Atmaca · 2024 · Diabetes Therapy
25. Clinical Implications of the ACCORD Trial
    SAUL M. GENUTH, Faramarz Ismail‐Beigi · 2011 · The Journal of Clinical Endocrinology & Metabolism
26. Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus
    Taina Mattila, Anthonius de Boer · 2010 · Drugs
27. Diabetes Mellitus and the Importance of Self-care
    MinKyoung Song · 2010 · The Journal of Cardiovascular Nursing
28. Diabetes and Stroke Prevention: A Review
    Jonathan Hewitt, Luis Castilla Guerra, María del Carmen Fernández‐Moreno, Cristina Sierra · 2012 · Stroke Research and Treatment
29. Dysglycaemia, vasculopenia, and the chronic consequences of diabetes
    Hertzel C. Gerstein, Geoff H. Werstuck · 2013 · The Lancet Diabetes & Endocrinology
30. Glucose variability indices predict the episodes of nocturnal hypoglycemia in elderly type 2 diabetic patients treated with insulin
    Vadim Valer'evich Klimontov, Natalia E. Myakina · 2016 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
31. Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?
    Konstantinos P. Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos, Michael N. Doumas, Asterios I. Karagiannis · 2016 · Journal of Neurology Neurosurgery & Psychiatry
32. Individual differences in regulatory mode moderate the effectiveness of a pilot mHealth trial for diabetes management among older veterans
    MICHELLE A. DUGAS, Kenyon Crowley, Guodong Gordon Gao, Timothy T. Xu, Ritu Agarwal, Arie W. Kruglanski, Nanette Steinle · 2018 · PLoS ONE
33. The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents
    Stephen Colagiuri, David Richard Matthews, Lawrence A. Leiter, Siew Pheng Chan, Giorgio Sesti, Michel Marre · 2018 · Diabetes Research and Clinical Practice
34. Veterans Affairs diabetes trial–corrections
    Moritz, Thomas, Duckworth, William, Abraira, Carlos · 2009 · New England Journal of Medicine
35. Prognostic implications of stress hyperglycemia ratio in patients with myocardial infarction with nonobstructive coronary arteries
    Side Gao, Sizhuang Huang, Xuze Lin, Li Xu, Mengyue Yu · 2023 · Annals of Medicine
36. Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions
    Jingyang Chen, Dong Yin, Kefei Dou · 2023 · Cardiovascular Diabetology
37. An observational study of patient characteristics and mortality following hypoglycemia in the community
    Francesca R Elwen, Alice C. Westwood, Linda Clapham, Matthew James Bottomley, Simon R. Heller, Cathryn James, Afroze Abbas, Paul David Baxter, Ramzi Ajjan · 2015 · BMJ Open Diabetes Research & Care
38. Are current clinical trials in diabetes addressing important issues in diabetes care?
    Wanda C. Lakey, Karen Barnard, Bryan C. Batch, Karen Chiswell, Ali Tasneem, J. B. Green · 2013 · Diabetologia
39. Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy
    A. Gordon Smith · 2012 · Journal of the Peripheral Nervous System
40. Are elderly patients with diabetes being overtreated in French long-term-care homes?
    Benjamin Bouillet, G Vaillant, Jean‐Michel Petit, Marc Duclos, Alix Poussier, Marie‐Claude Brindisi, Bruno L Vergès · 2010 · Diabetes & Metabolism
41. Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study.
    Christopher A. Newton, Saira Adeel, Shadi Sadeghi-Yarandi, Winter Powell, Alexandra L. Migdal, D. Smiley, D. Olson, Rakhee Chambria, I. Pinzón, M. T. Toyoshima et al. · 2013 · Journal of the American Medical Directors Association
42. Who Can Respond to Treatment?
    Sherrie H. Kaplan, John Billimek, Dara H. Sorkin, Quyen Ngo‐Metzger, Sheldon Greenfield · 2010 · Medical Care
43. Alleviating the burden of diabetic nephropathy
    Stephen P. Gray, Mark Emmanuel Cooper · 2011 · Nature Reviews Nephrology
44. Haptoglobin Genotype and Its Role in Diabetic Cardiovascular Disease
    Tina Costacou, Andrew P. Levy · 2012 · Journal of Cardiovascular Translational Research
45. Pistachio Nut Consumption Modifies Systemic Hemodynamics, Increases Heart Rate Variability, and Reduces Ambulatory Blood Pressure in Well‐Controlled Type 2 Diabetes: a Randomized Trial
    Katherine Ann Sauder, Cindy E McCrea, Jan S. Ulbrecht, Penny M. Kris‐Etherton, Sheila G. West · 2014 · Journal of the American Heart Association
46. High normal fasting glucose level in obese youth: a marker for insulin resistance and beta cell dysregulation
    Grace O’Malley, Nicola Santoro, Veronika S. Northrup, Ebe D’Adamo, Melissa M. Shaw, Samuel Eldrich, Sonia Caprio · 2010 · Diabetologia
47. Costs associated with emergency care and hospitalization for severe hypoglycemia
    Giacomo Veronese, Giulio Marchesini, Gabriele Forlani, Stefania Saragoni, Luca Degli Esposti, Elena Centis, Andrea Fabbri · 2016 · Nutrition Metabolism and Cardiovascular Diseases
48. Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
    Juraj Koška, Hussein N. Yassine, Olgica Trenchevska, Shripad A. Sinari, Dawn C. Schwenke, Frances T. Yen, Dean D. Billheimer, Randall W. Nelson, Dobrin Nedelkov, Peter D. Reaven · 2016 · Journal of Lipid Research
49. Approach to diabetes management in patients with CVD
    Sanam Lathief, Silvio E. Inzucchi · 2015 · Trends in Cardiovascular Medicine
50. Evidence-based recommendations and expert consensus on enteral nutrition in the adult patient with diabetes mellitus or hyperglycemia
    Alejandro Sanz‐París, Julia Álvarez Hernández, María Dolores Ballesteros-Pomar, Francisco Botella Romero, Miguel León-Sanz, Ángela Martín-Palmero, Miguel Ángel Martínez Olmos, Gabriel Olveira · 2017 · Nutrition
51. Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users
    Anthony P. Nunes, Kristy Iglay, Larry Radican, Samuel S. Engel, H. J. Yang, Michael C. Doherty, David D. Dore · 2017 · Diabetes Obesity and Metabolism
52. Diabetic Autonomic Neuropathy
    Zdravko Asenov Kamenov, Latchezar Dintchov Traykov · 2012 · Advances in experimental medicine and biology
53. DIRETRIZ BRASILEIRA BASEADA EM EVIDÊNCIAS SOBRE PREVENÇÃO DE DOENÇAS CARDIOVASCULARES EM PACIENTES COM DIABETES: POSICIONAMENTO DA SOCIEDADE BRASILEIRA DE DIABETES (SBD), DA SOCIEDADE BRASILEIRA DE CARDIOLOGIA (SBC) E DA SOCIEDADE BRASILEIRA DE ENDOCRINOLOGIA E METABOLOGIA (SBEM)
    AA Faludi, MCO Izar, JFK Saraiva, Henrique Tria Bianco, APM Chacra, Marcello Bertoluci, RO Moreira, LAA Turatti, Adriana Bertolami, Martha L. Sulzbach et al. · 2017 · Arquivos Brasileiros de Cardiologia
54. A1C targets should be personalized to maximize benefits while limiting risks
    Riddle, Matthew C., Gerstein, Hertzel C., Holman, Rury R., Inzucchi, Silvio E., Zinman, Bernard, Zoungas, Sophia, Cefalu, William T. · 2018 · Diabetes Care
55. High rates of severe hypoglycemia among African American patients with diabetes: the surveillance, prevention, and Management of Diabetes Mellitus (SUPREME-DM) network
    Karter, Andrew J, Lipska, Kasia J, O’Connor, Patrick J., Liu, Jennifer Y., Moffet, Howard H, Schroeder, Emily B., Lawrence, Jean M., Nichols, Gregory A., Newton, Katherine M, Pathak, Ram D. et al. · 2017 · Journal of Diabetes and its Complications
56. Effect of glucose-lowering therapies on heart failure
    Michael E. Nassif, Mikhail Kosiborod · 2018 · Nature Reviews Cardiology
57. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2015 Executive Summary
    Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel E. Dagogo-Jack, Michael Davidson, DANIEL F. EINHORN, Jeffrey R. Garber et al. · 2015 · Endocrine Practice
58. Diabetes mellitus type 2 in adults
    Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Alexander Yu. Mayorov, Минара Шамхаловна Шамхалова, Olga Yu. Sukhareva, Gagik Radikovich Galstyan, Alla Yur'evna Tokmakova, Tatiana Vasil'evna Nikonova, Elena Viktorovna Surkova, Ирина Владимировна Кононенко et al. · 2020 · Diabetes Mellitus
59. Incretin agents in type 2 diabetes.
    Stuart A. Ross, Jean-Marie Ékoé · 2010 · PubMed Central
60. Perioperative management of ambulatory surgical patients with diabetes mellitus
    Mary Ann Vann · 2009 · Current Opinion in Anaesthesiology
61. Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes
    Louis Potier, Ludovic Waeckel, Marie‐Pascale Vincent, Catherine Chollet, Fernand Gobeil, Michel Marre, Patrick Bruneval, Christine Richer, Ronan Roussel, François Alhenc‐Gelas et al. · 2013 · Journal of Pharmacology and Experimental Therapeutics
62. Wherefore Art Thou, O Treatment for Diabetic Neuropathy?
    Rayaz Ahmed Malik · 2016 · International review of neurobiology
63. Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?
    Francesco Giorgino, Philip Home, Jaakko O. Tuomilehto · 2016 · Diabetes Care
64. Trajectories of fasting plasma glucose variability and mortality in type 2 diabetes
    Chia-Lin Lee, Wayne Huey‐Herng Sheu, I‐Te Lee, Shih‐Yi Lin, Wen‐Miin Liang, Jun‐Sing Wang, Yufen Li · 2017 · Diabetes & Metabolism
65. Improvements of ambient hyperglycemia and glycemic variability are associated with reduction in oxidative stress for patients with type 2 diabetes
    Makoto Ohara, Hiroe Nagaike, Satoshi Goto, Ayako Fukase, Yuki Tanabe, Masako Tomoyasu, Takeshi Yamamoto, Toshiyuki Hayashi, Tomoyasu Fukui, Tsutomu Hirano · 2018 · Diabetes Research and Clinical Practice
66. Stroke in the elderly
    Anjail Zarinah Sharrief, James C. Grotta · 2019 · Handbook of clinical neurology
67. Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late
    Saad Javed, Tabraiz Hayat, L. Menon, Uazman Alam, Rayaz Ahmed Malik · 2019 · Diabetic Medicine
68. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: A preliminary report
    Matsutani, Daisuke, Sakamoto, Masaya, Iuchi, Hiroyuki, Minato, Souichirou, Suzuki, Hirofumi, Kayama, Yosuke, Takeda, Norihiko, Horiuchi, Ryuzo, Utsunomiya, Kazunori · 2018 · Cardiovascular Diabetology
69. Defective Counterregulation and Hypoglycemia Unawareness in Diabetes
    Candace M. Reno, Marina Litvin, Amy L. Clark, Simon J. Fisher · 2012 · Endocrinology and Metabolism Clinics of North America
70. The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype
    Leah E. Cahill, Majken K. Jensen, Stephanie E. Chiuve, Hadar Shalom, Jennifer K. Pai, Alan J. Flint, Kenneth Jay Mukamal, Kathryn M. Rexrode, Andrew P. Levy, Eric B. Rimm · 2015 · Journal of the American College of Cardiology
71. Benefits of timely basal insulin control in patients with type 2 diabetes
    Dragana Lovre, Vivian Andrew Fonseca · 2014 · Journal of Diabetes and its Complications
72. Hyperglycemia following recovery from hypoglycemia worsens endothelial damage and thrombosis activation in type 1 diabetes and in healthy controls
    Antonio Ceriello, Anna Novials, E. Ortega, Gemma Pujadas, Lucia La Sala, Roberto Testa, Anna Rita Bonfigli, Stefano Genovese · 2013 · Nutrition Metabolism and Cardiovascular Diseases
73. Targeted learning in real‐world comparative effectiveness research with time‐varying interventions
    Romain S. Neugebauer, Julie A. Schmittdiel, Mark J. van der Laan · 2014 · Statistics in Medicine
74. Thiazolidinediones: A 2010 Perspective
    Ashok Krishnaswami, Shalini Ravi-Kumar, John M Lewis · 2010 · The Permanente Journal
75. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
    Jin Kyung Hwang, Seung Hwa Lee, Young Bin Song, Joonghyun Ahn, Keumhee Chough Carriere, Mi Ja Jang, Taek Kyu Park, Seung‐Hyuk Choi, Jeong Hoon Yang, Jin‐Ho Choi et al. · 2017 · Circulation Cardiovascular Interventions
76. Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes
    Jordi Merino, Aaron Leong, Daniel C. Posner, Bianca Porneala, L. Masana, Josée Dupuis, José C. Florez · 2017 · Diabetes Care
77. Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy
    April Cox, Yves Sagot, Gaël Hédou, Christina L. Grek, Travis Wilkes, Aaron I. Vinik, Gautam S. Ghatnekar · 2017 · Frontiers in Endocrinology
78. Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis
    Shuang Liang, Hang Yin, Chunxiang Wei, Linjun Xie, Hua He, Xiaoquan Liu · 2017 · Journal of Diabetes & Metabolic Disorders
79. Visit-to-visit HbA1c and glucose variability and the risks of macrovascular and microvascular events in the general population
    Ji‐Yong Jang, Shinje Moon, Sungsoo Cho, Kyoo Ho Cho, Chang‐Myung Oh · 2019 · Scientific Reports
80. The Global Burden of Diabetes
    Mohammed Kumail Ali · 2016 · Wiley eBooks
81. Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home
    Azelton, Kimberly R., Crowley, Aidan P., Vence, Nicholas, Underwood, Karin, Morris, Gerald, Kelly, John, Landry, Matthew J. · 2021 · Frontiers in Digital Health
82. Diabetes and Cardiovascular Disease Prevention in Older Adults
    Cigolle, Christine T., Blaum, Caroline S., Halter, Jeffrey B. · 2009 · Clinics in Geriatric Medicine
83. An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment
    Makam, Anil N., Nguyen, Oanh K. · 2017 · Circulation
84. Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope
    Dario Giugliano, Juris Jendrik Meier, Katherine Esposito · 2019 · Diabetes Obesity and Metabolism
85. Understanding the drivers and consequences of early-onset type 2 diabetes
    Lee‐Ling Lim, Sophie Jones, Justin Cirhuza Cikomola, Marie‐France Hivert, Shivani Misra · 2025 · The Lancet
86. Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)‐TIMI 53 trial
    Ofri Mosenzon, Itamar Raz, Benjamin M. Scirica, Boaz Hirshberg, Christina Stahre, Philippe Gabríel Steg, Jaime A. Davidson, Peter Öhman, D. L. Price, Bob Frederich et al. · 2013 · Diabetes/Metabolism Research and Reviews
87. Does Clinical Inertia Vary by Personalized A1C Goal? A Study of Predictors and Prevalence of Clinical Inertia In A U.S. Managed-Care Setting
    Lin, Jay, Zhou, Steve, Wei, Wenhui, Pan, Chunshen, Lingohr-Smith, Melissa, Levin, Philip · 2016 · Endocrine Practice
88. Multidrug Treatment of Type 2 Diabetes
    Roberto Miccoli, Giuseppe Penno, Stefano Del Prato · 2011 · Diabetes Care
89. PANORAMA: A European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus—Study design
    Clare Bradley, Pedro Luis de Pablos-Velasco, Klaus Georg Parhofer, É. Eschwège, Linda A Gonder-Frederick, D. Simon · 2011 · Primary care diabetes
90. Relación del grado de control glucémico con las características de la diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2. Estudio DIABES
    Antonio Pérez, Josep Franch‐Nadal, Aleix Cases, José Ramón González‐Juanatey, Pedro Conthe, Eva Gimeno, Arantxa Matalí · 2011 · Medicina Clínica
91. Vascular Calcification in Diabetes: Mechanisms and Implications
    Janet K. Snell‐Bergeon, Matthew Jay Budoff, John E. Hokanson · 2013 · Current Diabetes Reports
92. Drug-induced hypoglycaemia in type 2 diabetes
    Berit Inkster, Nicola N. Zammitt, Brian M. Frier · 2012 · Expert Opinion on Drug Safety
93. Liraglutide (victoza): the first once-daily incretin mimetic injection for type-2 diabetes.
    Sylvia Jackson, Tonya S. Martin, Jocelyn D. Jones, David Seal, Frank S. Emanuel · 2010 · PubMed Central
94. Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists
    Avivit Cahn, Itamar Raz, Yosef Kleinman, Ran D. Balicer, Moshe Hoshen, Nicky Lieberman, Naomi Brenig, Stefano Del Prato, William T. Cefalu · 2015 · Diabetes Care
95. Dried Saliva Spot (DSS) as a Convenient and Reliable Sampling for Bioanalysis: An Application for the Diagnosis of Diabetes Mellitus
    Masahiro Numako, Takahiro Takayama, Ichiro Noge, Yutaka Kitagawa, Kenichiro Todoroki, Hajime Mizuno, Jun Zhe Min, Toshimasa Toyo’oka · 2015 · Analytical Chemistry
96. Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β‐cells in db/db mice: The earlier and longer, the better
    Tomohiko Kimura, Atsushi Obata, Masashi Shimoda, Seizo Okauchi, Yukiko Kanda‐Kimura, Yuka Nogami, Saeko Moriuchi, Hidenori Hirukawa, Kenji Kohara, Shuhei Nakanishi et al. · 2018 · Diabetes Obesity and Metabolism
97. SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
    Amar Ali, Steve C Bain, Debbie Hicks, Phillip Newland Jones, Dipesh Patel, Marc Evans, Kevin Fernando, June James, Nicola Milne, Adie Viljoen et al. · 2019 · Diabetes Therapy
98. Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk
    Jeffrey Wayne Stephens, Karen E. Brown, Thinzar Min · 2020 · Diabetes Obesity and Metabolism
99. Diabetes after Bariatric Surgery
    Shah, Ankit, Laferrère, Blandine · 2017 · Canadian Journal of Diabetes
100. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes
     McCoy, Rozalina G, Lipska, Kasia J, Van Houten, Holly K, Shah, Nilay D · 2020 · BMJ Open Diabetes Research & Care